Search
for
Sort by
Research 661–690 of 1000+
- Primary cicatricial alopecia
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Diagnosis of hyperandrogenism: Biochemical criteria
- Alopecia: evaluation and treatment
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Female Pattern Hair Loss
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Nonclassic Congenital Adrenal Hyperplasia
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
- Toward a Diagnostic Score in Cushing's Syndrome
- The nocebo effect: A clinicians guide
- Polycystic ovary syndrome (PCOS)
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Side effects of common acne treatments
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Hair problems in women
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Interventions for female pattern hair loss
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Gender-Affirming Hormone Therapy for Transgender Men
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- The rationale for physiological testosterone replacement in women